Canopy Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Canopy Biosciences's estimated annual revenue is currently $13.6M per year.
- Canopy Biosciences's estimated revenue per employee is $155,000
- Canopy Biosciences's total funding is $4.4M.
Employee Data
- Canopy Biosciences has 88 Employees.
- Canopy Biosciences grew their employee count by 24% last year.
Canopy Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP BioPharma | Reveal Email/Phone |
2 | Head, Biopharma business | Reveal Email/Phone |
3 | VP, Product Development and Commercialization | Reveal Email/Phone |
4 | Head Clinical Development | Reveal Email/Phone |
5 | Associate Director Product Management | Reveal Email/Phone |
6 | Director Operations | Reveal Email/Phone |
7 | Chief Financial Officer | Reveal Email/Phone |
8 | Director Product Management | Reveal Email/Phone |
9 | Chief Scientific Officer | Reveal Email/Phone |
10 | Director Business Development - Europe | Reveal Email/Phone |
Canopy Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $79.1M | 510 | 6% | N/A | N/A |
#2 | $1.1M | 7 | 17% | N/A | N/A |
#3 | $4.2M | 27 | -32% | N/A | N/A |
#4 | $2M | 13 | 30% | N/A | N/A |
#5 | $4.3M | 28 | 4% | N/A | N/A |
#6 | $0.9M | 6 | 0% | N/A | N/A |
#7 | $5M | 32 | 3% | N/A | N/A |
#8 | $3.7M | 24 | 4% | N/A | N/A |
#9 | $0.3M | 4 | 0% | N/A | N/A |
#10 | $6M | 39 | 50% | N/A | N/A |
What Is Canopy Biosciences?
Canopy Biosciences aims to accelerate the commercialization of life science reagent tools and services through in-licensing key technologies in the fields of genetic engineering and personalized medicine. Founded in 2016, Canopy has offices and laboratories in St. Louis, MO.
keywords:N/A
$4.4M
Total Funding
88
Number of Employees
$13.6M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Canopy Biosciences News
Canopy Biosciences' CellScape is the latest generation ChipCytometry instrument, which enables high-plex spatial imaging and quantification...
Canopy Biosciences' CellScape is the latest generation ChipCytometry TM instrument, which enables high-plex spatial imaging and...
Canopy Biosciences is headquartered in St. Louis, Missouri, with a CLIA site in California, and a site in Germany to serve researchers at...
Canopy Biosciences, a St. Louis, MO-based provider of gene editing and gene expression products and services, acquired Zellkraftwerk GmbH, a Leipzig, Germany-based multiplex cytometry company. Concurrent with the acquisition, Canopy closed a strategic growth investment from Ampersand Capital Pa ...
Canopy Biosciences, a St. Louis-based life sciences company, closed a $2.4m Series A financing. BioGenerator, the investment arm of BioSTL, and Kingdom Capital co-led the round, which saw participation from The Missouri Technology Corporation (MTC), PinPoint Holdings, Greenleaf Fund, and Arch A ...
Other Companies in St. Louis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $22.1M | 88 | 4% | N/A |
#2 | $23.8M | 88 | 0% | N/A |
#3 | $23.8M | 88 | 7% | N/A |
#4 | $18.5M | 88 | 2% | N/A |
#5 | $28.9M | 88 | 6% | N/A |